Patents by Inventor Derek N. J. Hart

Derek N. J. Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human CMRF-35-H9 receptor which binds IgM
    Publication number: 20040053364
    Abstract: The invention relates to the receptor CMRF-35-H9 which inter alia bind immunoglobulin M (IgM). The receptor, together with peptides encoding its extracellular domain, have application in methods of immunomodulation, including in the blocking or inhibition of humoral immune responses in transplant patients.
    Type: Application
    Filed: January 31, 2003
    Publication date: March 18, 2004
    Applicant: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventor: Derek N.J. Hart
  • Human CMRF-35-H9 receptor which binds IgM
    Patent number: 6617428
    Abstract: Isolated receptor CMRF-35-H9 having an amino acid sequence as set out in SEQ ID NO:1, or a derivative thereof which binds IgM. The receptor, together with peptides encoding its extracellular domain, have application in methods of immunomodulation, including the blocking or inhibition of humoral immune responses in transplant patients.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: September 9, 2003
    Assignee: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventor: Derek N. J. Hart
  • Dendritic cell-specific antibodies
    Patent number: 6479247
    Abstract: Isolated antibody or preparation of antibodies comprising an antigen-binding domain wherein the antigen is present on activated dendritic cells and wherein the antibody does not interact with CMRF-44 antigen or CD83 antigen.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: November 12, 2002
    Assignee: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventor: Derek N. J. Hart
  • DENDRITIC CELL-SPECIFIC ANTIBODIES
    Publication number: 20020155510
    Abstract: This invention describes antibodies specific for an activation antigen, CMRF-56, on activated dendritic cells Monoclonal antibody (mAb) CMRF-56 is specifically described. The use of such antibodies for both therapy and prophylaxis, and in immunological-based processes for purifying activated dendritic cells is also described.
    Type: Application
    Filed: April 29, 1999
    Publication date: October 24, 2002
    Inventor: DEREK N.J. HART
  • Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity
    Publication number: 20020035078
    Abstract: Enzyme having AHCY-type activity and DNA sequences which encode the enzyme. The enzyme is useful in a screening assay to identify compounds useful as immunosuppression agents.
    Type: Application
    Filed: February 14, 2001
    Publication date: March 21, 2002
    Applicant: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland.
    Inventor: Derek N.J. Hart
  • Dendritic cell-specific antibodies and method for their preparation
    Patent number: 5876917
    Abstract: This invention describes methods for generating antibodies specific for activation antigen CMRF-44 on activated dendritic cells, and antibodies produced by the method. The use of such antibodies, including monoclonal antibody CMRF-44, in immunological-based processes and systems for purifying and/or identifying activated dendritic cells is also described.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: March 2, 1999
    Assignee: Canterbury Health Limited
    Inventor: Derek N. J. Hart